RecruitingNot ApplicableNCT05711173

Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)

Role of Clonal Hematopoiesis and NETs Formation in Unusual Venous Thrombosis (CLODETTE)


Sponsor

University Hospital, Bordeaux

Enrollment

150 participants

Start Date

Mar 3, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Thrombo-embolic venous diseases are represented by deep venous thrombosis and/or pulmonary embolism. In some patients with repeated thrombosis or occurrence of thrombosis in unusual sites, the etiological workup remains negative, which represents a problem for the management of the anticoagulant treatments. Recently, two factors have been identified as important in the physiopathology of hemostasis and coagulation: the presence of clonal hematopoiesis of indetermined potential (CHIP) and the formation of neutrophil extracellular traps (NETs). In this study, these two factors will be studied in patients with repeated venous thrombosis or thrombosis occurring in unusual site.


Eligibility

Min Age: 6 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Additional blood sampling for people with clonal hematopoiesis of indeterminate potential, neutrophil extracellular trap formation, and other related conditions. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 6 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALAdditional blood sampling

The procedure will consist of an additional blood sample for ETDA tube collection (NGS analysis) and citrate tube collection (NETose analysis)


Locations(7)

CHU de Bordeaux, Service de Neurologie

Bordeaux, France

CHU de Bordeaux, Service Gastro-Entérologie

Bordeaux, France

CHU de Bordeaux, Service Hématologie Biologique

Bordeaux, France

CHU de Bordeaux, Service Médecine Vasculaire

Bordeaux, France

CHU de Bordeaux, Unité ambulatoire de Médecine Vasculaire

Bordeaux, France

CHU de Lille, Service Hémostase Clinique

Lille, France

APHM - Hôpital de la Timone, Service Hématologie

Marseille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05711173


Related Trials